Monarch Cement (OTCMKTS:MCEM – Get Free Report) and Amrize (NYSE:AMRZ – Get Free Report) are both materials companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, earnings, dividends, analyst recommendations, institutional ownership and valuation.
Dividends
Monarch Cement pays an annual dividend of $3.68 per share and has a dividend yield of 1.4%. Amrize pays an annual dividend of $0.44 per share and has a dividend yield of 1.0%. Monarch Cement pays out 18.2% of its earnings in the form of a dividend. Amrize pays out 20.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Monarch Cement is clearly the better dividend stock, given its higher yield and lower payout ratio.
Profitability
This table compares Monarch Cement and Amrize’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Monarch Cement | 28.98% | 17.38% | 15.22% |
| Amrize | 9.89% | 10.22% | 5.48% |
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Monarch Cement | $248.26 million | 4.09 | $89.32 million | $20.22 | 13.43 |
| Amrize | $12.18 billion | 2.07 | $1.19 billion | $2.17 | 21.04 |
Amrize has higher revenue and earnings than Monarch Cement. Monarch Cement is trading at a lower price-to-earnings ratio than Amrize, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Monarch Cement has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Comparatively, Amrize has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Monarch Cement and Amrize, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Monarch Cement | 0 | 0 | 0 | 0 | 0.00 |
| Amrize | 2 | 5 | 9 | 1 | 2.53 |
Amrize has a consensus price target of $60.57, suggesting a potential upside of 32.66%. Given Amrize’s stronger consensus rating and higher possible upside, analysts plainly believe Amrize is more favorable than Monarch Cement.
Summary
Monarch Cement beats Amrize on 8 of the 15 factors compared between the two stocks.
About Monarch Cement
The Monarch Cement Company engages in the manufacture and sale of portland cement in the United States. The company also provides masonry cement, ready-mixed concrete, concrete products, and sundry building materials. It primarily serves contractors, ready-mixed concrete plants, concrete products plants, building materials dealers, and governmental agencies. The company sells its products principally in the State of Kansas, the State of Iowa, southeast Nebraska, western Missouri, northwest Arkansas, and northern Oklahoma. The Monarch Cement Company was founded in 1908 and is based in Humboldt, Kansas.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Receive News & Ratings for Monarch Cement Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monarch Cement and related companies with MarketBeat.com's FREE daily email newsletter.
